LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
1
 18.98 27.76 1085 941 1.1529 1.0568
MN20160318_Q01
K06
MCF 10A-H2B-mCherry Trametinib
1
 20.68 27.76 33 1119 0.0295 0.0330
MN20160318_Q01
E15
MCF 10A-H2B-mCherry Trametinib
1
 20.68 27.76 940 1119 0.8400 0.9357
MN20160318_Q01
E15
MCF 10A-H2B-mCherry Trametinib
1
 20.68 27.76 1016 1119 0.9080 0.9641
MN20160318_Q01
K06
MCF 10A-H2B-mCherry Trametinib
1
 20.68 27.76 1096 1119 0.9795 0.9922
MN20160318_Q01
K06
MCF 10A-H2B-mCherry Trametinib
1
 22.39 27.76 42 1305 0.0322 0.0774
MN20160318_Q01
E15
MCF 10A-H2B-mCherry Trametinib
1
 22.39 27.76 972 1305 0.7444 0.8965
MN20160318_Q01
E15
MCF 10A-H2B-mCherry Trametinib
1
 22.39 27.76 1030 1305 0.7888 0.9164
MN20160318_Q01
K06
MCF 10A-H2B-mCherry Trametinib
1
 22.39 27.76 1085 1305 0.8310 0.9344
MN20160318_Q01
K06
MCF 10A-H2B-mCherry Trametinib
1
 24.09 27.76 55 1461 0.0376 0.1270
MN20160318_Q01
E15
MCF 10A-H2B-mCherry Trametinib
1
 24.09 27.76 1004 1461 0.6869 0.8729
MN20160318_Q01
E15
MCF 10A-H2B-mCherry Trametinib
1
 24.09 27.76 1000 1461 0.6842 0.8716
MN20160318_Q01
K06
MCF 10A-H2B-mCherry Trametinib
1
 24.09 27.76 1049 1461 0.7177 0.8873
MN20160318_Q01
K06
MCF 10A-H2B-mCherry Trametinib
1
 25.79 27.76 47 1605 0.0293 0.0941
MN20160318_Q01
E15
MCF 10A-H2B-mCherry Trametinib
1
 25.79 27.76 936 1605 0.5831 0.8240
MN20160318_Q01
E15
MCF 10A-H2B-mCherry Trametinib
1
 25.79 27.76 1027 1605 0.6398 0.8531
MN20160318_Q01
K06
MCF 10A-H2B-mCherry Trametinib
1
 25.79 27.76 1066 1605 0.6641 0.8649
MN20160318_Q01
K06
MCF 10A-H2B-mCherry Trametinib
1
 27.49 27.76 68 1723 0.0395 0.1623
MN20160318_Q01
E15
MCF 10A-H2B-mCherry Trametinib
1
 27.49 27.76 945 1723 0.5484 0.8081
MN20160318_Q01
E15
MCF 10A-H2B-mCherry Trametinib
1
 27.49 27.76 988 1723 0.5734 0.8217
MN20160318_Q01
K06
MCF 10A-H2B-mCherry Trametinib
1
 27.49 27.76 1026 1723 0.5954 0.8333
MN20160318_Q01
K06
MCF 10A-H2B-mCherry Trametinib
1
 29.19 27.76 81 1863 0.0435 0.1930
MN20160318_Q01
E15
MCF 10A-H2B-mCherry Trametinib
1
 29.19 27.76 916 1863 0.4916 0.7792
MN20160318_Q01
E15
MCF 10A-H2B-mCherry Trametinib
1
 29.19 27.76 1025 1863 0.5502 0.8125
MN20160318_Q01
K06
MCF 10A-H2B-mCherry Trametinib
1
 29.19 27.76 1064 1863 0.5711 0.8236
MN20160318_Q01
K06